Dr. George J. Michel, MD

Dr. Michel practices at Larkin Hospital South Miami in South Miami, Florida, part of Larkin Community Hospital.

Dr. Michel's NPI, 1558583997, was assigned on May 3, 2007. Dr. Michel graduated from University of Miami, Miller School of Medicine in 1993. Dr. Michel holds Florida license ME67268.

Dr. Michel's primary practice is Larkin Hospital South Miami, at 7031 Sw 62nd Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (305) 284-7500.

Dr. Michel's primary practice is Larkin Hospital South Miami in South Miami, Florida, part of Larkin Community Hospital. The medical group on file is First Docs. Dmand AI also links Dr. Michel to 6 more medical groups, 3 group practices and clinics, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Michel practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Michel's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Michel is board certified in internal medicine by the American Board of Internal Medicine. Dr. Michel is licensed in Florida.

Dmand AI lists acute diabetes, acute skin infection, anemia, asthma, bile duct problems, cardiac arrhythmia, chronic anemia and chronic diabetes among the conditions Dr. Michel treats.

CMS data shows 1,360 Medicare services from Dr. Michel across 7 procedure codes in 2024, for 211 Medicare patients. Medicare paid $101,237 for them.

CMS counts 211 Medicare patients who saw Dr. Michel in 2024. The largest group is under 65, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 79% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Michel's median patient age at 72, with 49% women.

In 2024, Dr. Michel wrote 2,051 Medicare Part D claims for 200 patients. 92% of them were for generic drugs. CMS names the drug for 1,605 of them, across 51 drugs with 11 or more claims each, at $64,392 in total drug cost. In 2023, CMS named 918 claims across 37 drugs.

Dr. Michel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Michel as offering telehealth.

Dmand AI links 46 papers to Dr. Michel, published from 2007 to 2023. 2022 was the busiest year, with 5. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Precursor Cell Lymphoblastic Leukemia-Lymphoma. Dr. Michel has published most often in Bone Marrow Transplant. Dr. Michel's most frequent co-authors are Pedram Rad, MD, Jack Jacobo Michel, MD and Odalys P. Frontela, MD.

CMS Open Payments shows 5 general payments to Dr. Michel from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $125.

Dr. Michel graduated from University of Miami, Miller School of Medicine in 1993.

Dr. Michel is in network with 9 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.